Malignant neoplasm
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Male and female patients (aged over 20 years) who were low emetic chemotherapy naive and scheduled to receive at least one cycles of chemotherapy 2.Patients can note in the patient diaries 3.Patients gave written informed consent
Exclusion criteria
Exclusion criteria: 1.Patients experienced CINV within 24 hours before chemotherapy 2.Patients judged unqualified for any reasons by the principal investigator or investigators at study sites
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of CINV and the risk factors predicting CINV in LEC | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.incidence of CINV (overall, acute phase and delayed phase) 2.pattern of nausea incidence and severity 3.decrease of food intake 4.rescue medication use | — |
Countries
Japan
Contacts
National Kyushu Medical Center Department of pharmacy